75F40123F19004↗

Deloitte Consulting LLP received this contract from Fda Office of Acq Grant Svcs, Food and Drug Administration: $252.7K obligated so far for special studies/analysis- regulatory. Its period of performance ended 2024-07-02.

Key facts · data as of Oct 26, 2026

Recipient
Deloitte Consulting LLP
Awarding agency
Food and Drug Administration (Department of Health and Human Services)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Obligated to date
$252.7K
Potential value
$252.7K
Ends
2024-07-02

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 26, 2026.

Cite this page: SpendQuery, Award 75F40123F19004, data as of Oct 26, 2026, https://spendquery.com/award?id=CONT_AWD_75F40123F19004_7524_75F40122A00018_7524

THIS IS A FIRM FIXED PRICE (FFP) TASK ORDER TO ACQUIRER DRUG LABELING INITIATIVE.

Bpa Call · Food and Drug Administration · to Deloitte Consulting LLP (UEI CKV2L9GZKJK3) · data as of 2026-10-26

Obligated to date$252.7K1 action
Current value$252.7Kwith options exercised
Period2023-06-27 → 2024-07-02current end date

What it is

Product or service
Special Studies/Analysis- Regulatory (PSC B528)
Industry
All Other Professional, Scientific, and Technical Services (NAICS 541990)
Contracting office
Fda Office of Acq Grant Svcs (75F401)
Competition
Not competed under simplified acquisition · 1 offer received
Pricing
Firm fixed price
How it was bought
Blanket purchase agreement (BPA) · under 75F40122A00018
Where the work is
Arlington, VA · district VA-08

Obligations by fiscal year

FY2023$252.7K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

1 action since 2023-06-27. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2023-06-270$252.7KTHIS IS A FIRM FIXED PRICE (FFP) TASK ORDER TO ACQUIRER DRUG LABELING INITIATIVE.

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-26). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗